Philip T. Ninan

 

 

 

 

 

 

 

 

 

 

 

 

 

In this review article, examine the risk of depression onset in perimenopausal and postmenopausal women and find out how to screen for and manage depression in your perimenopausal and...

This analysis of data from 10 studies examined weight change during short- and longer-term treatment with desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor. 

When your patients' depressive episodes have not fully remitted with antidepressant therapy, do you consider augmenting with bright light therapy? This treatment modality is accepted for seasonal depression, but...

Read this article to examine results from a randomized, open-label, multicenter study that compared treatment outcomes with the serotonin-norepinephrine reuptake inhibitor venlafaxine extended release with selective serotonin reuptake inhibitors...

Here, review results from a post hoc analysis that evaluated the tolerability of long-term desvenlafaxine for major depressive disorder at discontinuation using a taper regimen compared with abrupt discontinuation.Â